[HTML][HTML] Mesenchymal stem cell therapy in type 2 diabetes mellitus

L Zang, H Hao, J Liu, Y Li, W Han, Y Mu - Diabetology & metabolic …, 2017 - Springer
Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative
insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic …

[HTML][HTML] Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy

M Lv, M Chen, R Zhang, W Zhang, C Wang, Y Zhang… - Cell research, 2020 - nature.com
CD8+ T cell-mediated cancer clearance is often suppressed by the interaction between
inhibitory molecules like PD-1 and PD-L1, an interaction acts like brakes to prevent T cell …

[HTML][HTML] LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b

D Ti, H Hao, C Tong, J Liu, L Dong, J Zheng… - Journal of translational …, 2015 - Springer
Background Within the last few years, it has become evident that LPS-preconditioned
mesenchymal stromal cells (LPS pre-MSCs) show enhanced paracrine effects, including …

Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity

Y Si, Y Zhao, H Hao, J Liu, Y Guo, Y Mu, J Shen… - Diabetes, 2012 - Am Diabetes Assoc
Infusion of mesenchymal stem cells (MSCs) has been shown to effectively lower blood
glucose in diabetic individuals, but the mechanism involved could not be adequately …

Addition of low-dose decitabine to anti–PD-1 antibody camrelizumab in relapsed/refractory classical Hodgkin lymphoma

J Nie, C Wang, Y Liu, Q Yang, Q Mei, L Dong… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE Anti–programmed death-1 (PD-1) monotherapy induces a high response rate in
patients with relapsed/refractory classic Hodgkin lymphoma (cHL), but complete remission …

Core–shell structured Fe3O4@ TiO2-doxorubicin nanoparticles for targeted chemo-sonodynamic therapy of cancer

S Shen, L Wu, J Liu, M Xie, H Shen, X Qi, Y Yan… - International journal of …, 2015 - Elsevier
To facilitate targeting drug delivery and combined therapy, we develop titanium dioxide-
encapsulated Fe 3 O 4 nanoparticles (Fe 3 O 4@ TiO 2 NPs). Titanium dioxide (TiO 2) …

Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats

Z Xie, H Hao, C Tong, Y Cheng, J Liu, Y Pang, Y Si… - Stem …, 2016 - academic.oup.com
Insulin resistance, a major characteristic of type 2 diabetes (T2D), is closely associated with
adipose tissue macrophages (ATMs) that induce chronic low-grade inflammation. Recently …

Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats

H Hao, J Liu, J Shen, Y Zhao, H Liu, Q Hou… - Biochemical and …, 2013 - Elsevier
The worldwide rapid increase in diabetes poses a significant challenge to current
therapeutic approaches. Single-dose mesenchymal stem cell (MSC) infusion ameliorates …

Mesenchymal stem cell‐conditioned medium accelerates wound healing with fewer scars

M Li, F Luan, Y Zhao, H Hao, J Liu… - International wound …, 2017 - Wiley Online Library
Mesenchymal stem cells (MSCs) derived from umbilical cord s (UC‐MSCs) have been
shown to enhance cutaneous wound healing by means of the paracrine activity. Fibroblasts …

[HTML][HTML] Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 …

X Sun, H Hao, Q Han, X Song, J Liu, L Dong… - Stem cell research & …, 2017 - Springer
Background Insulin resistance is one of the most common and important pathological
features of type 2 diabetes (T2D). Recently, insulin resistance is increasingly considered to …